Clinical trial
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype - A Prospective Observational Study
NCT05574673 is registered in ClinicalTrials.gov with Nordic Society of Gynaecological Oncology - Clinical Trials Unit as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype - A Prospective Observational Study
- Lead sponsor
- Nordic Society of Gynaecological Oncology - Clinical Trials Unit
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 1, 2022
- Completion date
- July 1, 2032
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fallopian tube cancer, ovarian cancer, primary peritoneal cancer